Cabot Corporation

NYSE:CBT Voorraadrapport

Marktkapitalisatie: US$4.0b

Cabot Beheer

Beheer criteriumcontroles 3/4

De CEO Cabot is Sean Keohane, benoemd in Mar2016, heeft een ambtstermijn van 10.17 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 9.31M, bestaande uit 11.8% salaris en 88.2% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.59% van de aandelen van het bedrijf, ter waarde $ 23.73M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 7.5 jaar en 7 jaar.

Belangrijke informatie

Sean Keohane

Algemeen directeur

US$9.3m

Totale compensatie

Percentage CEO-salaris11.82%
Dienstverband CEO10.2yrs
Eigendom CEO0.6%
Management gemiddelde ambtstermijn7.5yrs
Gemiddelde ambtstermijn bestuur7yrs

Recente managementupdates

Recent updates

Seeking Alpha • Mar 26

Cabot: Competitive Pressures Due To High Tire Imports Continuing To Weigh

Summary Cabot Corporation continues to face sustained volume pressure in both Reinforcement Materials and Performance Chemicals, with management candid about ongoing macro headwinds. Despite Battery Materials revenue strength, EBIT in CBT's largest segment dropped by $28 million, and cost-cutting plus reduced capex signal a defensive near-term posture. Earnings are expected to fall by approximately 14% in fiscal 2026, with further downside risk due to recent downward EPS revisions and capacity rationalization plans. Technical analysis suggests the stock is consolidating at best, with broken support levels and weakening momentum likely leading to further downside; we maintain a bearish stance. Read the full article on Seeking Alpha
Analyseartikel • Nov 03

Should You Think About Buying Cabot Corporation (NYSE:CBT) Now?

While Cabot Corporation ( NYSE:CBT ) might not have the largest market cap around , it saw significant share price...
Analyseartikel • Sep 11

Cabot Corporation (NYSE:CBT) Screens Well But There Might Be A Catch

With a price-to-earnings (or "P/E") ratio of 10.1x Cabot Corporation ( NYSE:CBT ) may be sending bullish signals at the...
Analyseartikel • Jul 20

Is Cabot Corporation (NYSE:CBT) Trading At A 36% Discount?

Key Insights Cabot's estimated fair value is US$117 based on 2 Stage Free Cash Flow to Equity Cabot's US$74.90 share...
Analyseartikel • Jun 23

Shareholders Would Enjoy A Repeat Of Cabot's (NYSE:CBT) Recent Growth In Returns

There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...
Analyseartikel • Apr 25

These 4 Measures Indicate That Cabot (NYSE:CBT) Is Using Debt Reasonably Well

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analyseartikel • Apr 10

Cabot Corporation's (NYSE:CBT) Intrinsic Value Is Potentially 56% Above Its Share Price

Key Insights The projected fair value for Cabot is US$126 based on 2 Stage Free Cash Flow to Equity Cabot is estimated...
Analyseartikel • Mar 12

A Piece Of The Puzzle Missing From Cabot Corporation's (NYSE:CBT) Share Price

Cabot Corporation's ( NYSE:CBT ) price-to-earnings (or "P/E") ratio of 11x might make it look like a buy right now...
Seeking Alpha • Feb 13

Cabot Corporation: Reinforcing Positive Shareholder Value

Summary Cabot Corporation outperforms its sector, offering growth and income opportunities, making it a strong buy candidate. CBT's two segments, Reinforcement Materials and Performance Chemicals, show impressive EBIT margin growth and revenue recovery. CBT's growing EPS, strong cash flow, and aggressive share buyback program enhance its financial resilience and shareholder value. Trading near support levels, CBT offers good upside potential with a forward yield of 2%, despite potential tariff policy risks. Read the full article on Seeking Alpha
Seeking Alpha • Jan 30

Cabot: Eyeing Up A Bearish Position As We Approach Q1 Earnings (Technical Analysis)

Summary Cabot Corporation had a recent 25% drop and bearish MACD crossover, signaling potential technical weakness. The Reinforcement Materials segment continues to drive growth, but recent EPS and revenue revisions indicate challenges ahead. Fiscal 2024 revenue growth was flat, contrasting with a 5-year average of 4.59%, raising concerns about sustaining double-digit EPS growth. We expect earnings growth in Reinforcement Materials and a recovery in Performance Chemicals, but revenue growth remains crucial for CBT's long-term success. Read the full article on Seeking Alpha
Analyseartikel • Jan 29

Is There Now An Opportunity In Cabot Corporation (NYSE:CBT)?

Cabot Corporation ( NYSE:CBT ), might not be a large cap stock, but it received a lot of attention from a substantial...
Analyseartikel • Jan 15

Is Cabot (NYSE:CBT) Using Too Much Debt?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analyseartikel • Jan 02

Returns On Capital Are A Standout For Cabot (NYSE:CBT)

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Analyseartikel • Dec 06

Cabot Corporation (NYSE:CBT) Shares Could Be 31% Below Their Intrinsic Value Estimate

Key Insights The projected fair value for Cabot is US$150 based on 2 Stage Free Cash Flow to Equity Current share price...
Seeking Alpha • Nov 14

Cabot: Less Than 5% Annualized Upside

Summary Cabot Corporation has delivered a 50% total return in 1.5 years, surpassing expectations, but now trades at a premium valuation. Despite strong earnings and growth, Cabot's current valuation limits its upside, making it a "Hold" with a price target of $115/share. The company's fundamentals are solid, but market-beating returns are unlikely at current levels, prompting consideration for rotation into undervalued stocks. Cabot fulfills quality criteria but fails on valuation, justifying a cautious stance and potential sale above $115/share. Read the full article on Seeking Alpha
Analyseartikel • Oct 31

Here's Why We Think Cabot (NYSE:CBT) Might Deserve Your Attention Today

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Analyseartikel • Oct 19

Is There Now An Opportunity In Cabot Corporation (NYSE:CBT)?

Cabot Corporation ( NYSE:CBT ), is not the largest company out there, but it led the NYSE gainers with a relatively...
Analyseartikel • Oct 07

Improved Earnings Required Before Cabot Corporation (NYSE:CBT) Shares Find Their Feet

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 19x, you may...
Analyseartikel • Sep 25

Cabot (NYSE:CBT) Is Achieving High Returns On Its Capital

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...
Analyseartikel • Aug 19

Calculating The Intrinsic Value Of Cabot Corporation (NYSE:CBT)

Key Insights The projected fair value for Cabot is US$96.50 based on 2 Stage Free Cash Flow to Equity With US$99.26...
Seeking Alpha • Jul 31

Cabot Corporation: Now A 'Hold' (Rating Downgrade)

Summary Cabot Corporation has seen significant positive performance, up over 44% inclusive of dividends since January 19, 2023. The company has outperformed with good overall investment performance, showing resilience towards macro challenges. Despite recent growth, Cabot is now considered a "Hold" due to valuation concerns and moderate upside potential. Read the full article on Seeking Alpha
Analyseartikel • Jul 18

Cabot (NYSE:CBT) Will Pay A Dividend Of $0.43

Cabot Corporation's ( NYSE:CBT ) investors are due to receive a payment of $0.43 per share on 13th of September. Based...
Analyseartikel • Jun 23

Cabot (NYSE:CBT) Looks To Prolong Its Impressive Returns

What trends should we look for it we want to identify stocks that can multiply in value over the long term? One common...
Analyseartikel • Jun 09

Why Cabot Corporation (NYSE:CBT) Could Be Worth Watching

While Cabot Corporation ( NYSE:CBT ) might not have the largest market cap around , it saw a double-digit share price...
Analyseartikel • May 24

Cabot's (NYSE:CBT) Dividend Will Be Increased To $0.43

The board of Cabot Corporation ( NYSE:CBT ) has announced that it will be paying its dividend of $0.43 on the 14th of...
Seeking Alpha • May 16

Cabot: Reinforcement Materials Strength To Continue To Drive Earnings Forward

Summary Cabot Corporation's stock has returned approximately 38% since our 'Buy' recommendation in January. The company's Q2 earnings report showed impressive growth in both Performance Chemicals and the Reinforcement Materials business in particular. Cabot's cash flow is driving its financials, allowing for increased dividends and stock buybacks, and its forward-looking fundamentals remain bullish. Read the full article on Seeking Alpha
Analyseartikel • May 13

Cabot's (NYSE:CBT) Shareholders May Want To Dig Deeper Than Statutory Profit

The market for Cabot Corporation's ( NYSE:CBT ) stock was strong after it released a healthy earnings report last week...
Analyseartikel • May 10

Cabot's (NYSE:CBT) Upcoming Dividend Will Be Larger Than Last Year's

Cabot Corporation's ( NYSE:CBT ) dividend will be increasing from last year's payment of the same period to $0.43 on...
Analyseartikel • May 07

Here's Why Cabot (NYSE:CBT) Has Caught The Eye Of Investors

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Analyse CEO-vergoeding

Hoe is Sean Keohane's beloning veranderd ten opzichte van Cabot's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Mar 31 2026n/an/a

US$281m

Dec 31 2025n/an/a

US$306m

Sep 30 2025US$9mUS$1m

US$326m

Jun 30 2025n/an/a

US$418m

Mar 31 2025n/an/a

US$426m

Dec 31 2024n/an/a

US$417m

Sep 30 2024US$10mUS$1m

US$374m

Jun 30 2024n/an/a

US$470m

Mar 31 2024n/an/a

US$443m

Dec 31 2023n/an/a

US$433m

Sep 30 2023US$8mUS$1m

US$437m

Jun 30 2023n/an/a

US$300m

Mar 31 2023n/an/a

US$315m

Dec 31 2022n/an/a

US$348m

Sep 30 2022US$8mUS$1m

US$206m

Jun 30 2022n/an/a

US$142m

Mar 31 2022n/an/a

US$130m

Dec 31 2021n/an/a

US$98m

Sep 30 2021US$8mUS$1m

US$247m

Jun 30 2021n/an/a

-US$54m

Mar 31 2021n/an/a

-US$144m

Dec 31 2020n/an/a

-US$219m

Sep 30 2020US$6mUS$750k

-US$238m

Jun 30 2020n/an/a

US$65m

Mar 31 2020n/an/a

US$103m

Dec 31 2019n/an/a

US$127m

Sep 30 2019US$7mUS$988k

US$155m

Compensatie versus markt: De totale vergoeding ($USD 9.31M ) Sean } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 7.05M ).

Compensatie versus inkomsten: De vergoeding van Sean is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Sean Keohane (58 yo)

10.2yrs
Tenure
US$9,307,883
Compensatie

Mr. Sean D. Keohane serves as Independent Director of The Chemours Company since May 3, 2018. He has been the Chief Executive Officer and President of Cabot Corporation since March 11, 2016. He was a membe...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Sean Keohane
President10.2yrsUS$9.31m0.59%
$ 23.7m
Erica McLaughlin
Executive VP8yrsUS$2.78m0.097%
$ 3.9m
Karen Kalita
Senior VP & General Counsel6.9yrsUS$1.98m0.059%
$ 2.4m
Jeff Zhu
Executive VP14.1yrsUS$3.52m0.13%
$ 5.1m
Lisa Dumont
VP, Controller & Chief Accounting Officer6.3yrsgeen gegevens0.026%
$ 1.0m
Patricia Hubbard
Senior VP & CTO8.3yrsgeen gegevensgeen gegevens
Robert Rist
Vice President of Investor Relations & Corporate Planningless than a yeargeen gegevensgeen gegevens
Vanessa Craigie
Corporate Communications Directorno datageen gegevensgeen gegevens
Arthur Wood
Senior VP9.1yrsgeen gegevensgeen gegevens
Aaron Johnson
Senior VP of Global Business Services and Global Engineering & Inkjetno datageen gegevensgeen gegevens
Jaume Campana
SVP & President of EMEA Region and EMEA Regional Business Dir of Reinforcement Materials Segment2.7yrsgeen gegevensgeen gegevens
Jennifer Chittick
Senior VP of Safety2.3yrsgeen gegevensgeen gegevens
7.5yrs
Gemiddelde duur
53.5yo
Gemiddelde leeftijd

Ervaren management: Het managementteam van CBT is doorgewinterd en ervaren (gemiddelde ambtstermijn van 7.5 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Sean Keohane
President10.2yrsUS$9.31m0.59%
$ 23.7m
Raffiq Nathoo
Independent Director4yrsUS$250.11k0.018%
$ 725.9k
Douglas Del Grosso
Independent Director6.1yrsUS$250.25k0.012%
$ 465.5k
Cynthia Arnold
Independent Director8.3yrsUS$250.12k0.027%
$ 1.1m
Frank Wilson
Independent Director7.7yrsUS$270.43k0.036%
$ 1.5m
Thierry F. Vanlancker
Independent Director1.8yrsUS$250.05k0.0095%
$ 384.2k
Christine Yan
Independent Director7yrsUS$261.14k0.033%
$ 1.3m
Michael Morrow
Independent Non-Executive Chair8.7yrsUS$385.52k0.0039%
$ 156.5k
Michelle Williams
Independent Director2.7yrsUS$250.07k0.013%
$ 531.0k
7.0yrs
Gemiddelde duur
63yo
Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van CBT wordt beschouwd als ervaren (gemiddelde ambtstermijn 7 jaar).

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2026/05/22 22:56
Aandelenkoers aan het einde van de dag2026/05/22 00:00
Inkomsten2026/03/31
Jaarlijkse inkomsten2025/09/30

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen

* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

Cabot Corporation wordt gevolgd door 11 analisten. 5 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
Benjamin KalloBaird
Michael LeitheadBarclays
David BegleiterDeutsche Bank